Gynecologic Cancer,Ovarian Cancer BOOST Phase III Trial: Optimal Duration of Bevacizumab for Ovarian Cancer Mar 27, 2023
Gynecologic Cancer,Ovarian Cancer VELIA Trial: Veliparib as Maintenance Therapy for Frontline Ovarian Cancer Mar 27, 2023
Gynecologic Cancer,Ovarian Cancer Efficacy and Safety of Olaparib by Age in Ovarian Cancer Mar 27, 2023
Gynecologic Cancer,Ovarian Cancer Efficacy of Atezolizumab with Chemo and Bevacizumab in IMagyn050 Trial Mar 27, 2023
Cervical Cancer,Gynecologic Cancer Efficacy of Cemiplimab Monotherapy in Treating Cervical Cancer: EMPOWER-Cervical 1 Mar 27, 2023
Cervical Cancer,Gynecologic Cancer Efficacy of Pembrolizumab Monotherapy for Previously Untreated Cancer Patients Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Comparing ENZA + TALA to Placebo + ENZA in Treating mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer PROs of Pembrolizumab + Olaparib Treatment in Patients with mCRPC Mar 27, 2023
